BACKGROUND: A recent Cochrane meta-analysis did not confirm the benefits of fish and fish oil in the secondary prevention of cardiac death and myocardial infarction. We performed a meta-analysis of randomized controlled trials that examined the effect of fish-oil supplementation on ventricular fibrillation and ventricular tachycardia to determine the overall effect and to assess whether heterogeneity exists between trials. METHODS: We searched electronic databases (MEDLINE, EMBASE, The Cochrane Central Register of Controlled Trials, CINAHL) from inception to May 2007. We included randomized controlled trials of fish-oil supplementation on ventricular fibrillation or ventricular tachycardia in patients with implantable cardioverter defibrillators. The primary outcome was implantable cardioverter defibrillator discharge. We calculated relative risk [RR] for outcomes at 1-year follow-up for each study. We used the DerSimonian and Laird random-effects methods when there was significant heterogeneity between trials and the Mantel-Hanzel fixed-effects method when heterogeneity was negligible. RESULTS: We identified 3 trials of 1-2 years' duration. These trials included a total of 573 patients who received fish oil and 575 patients who received a control. Meta-analysis of data collected at 1 year showed no overall effect of fish oil on the relative risk of implantable cardioverter defibrillator discharge. There was significant heterogeneity between trials. The second largest study showed a significant benefit of fish oil (relative risk [RR] 0.74, 95% confidence interval [CI] 0.56-0.98). The smallest showed an adverse tendency at 1 year (RR 1.23, 95% CI 0.92-1.65) and significantly worse outcome at 2 years among patients with ventricular tachycardia at study entry (log rank p = 0.007). CONCLUSION: These data indicate that there is heterogeneity in the response of patients to fish-oil supplementation. Caution should be used when prescribing fish-oil supplementation for patients with ventricular tachycardia.
BACKGROUND: A recent Cochrane meta-analysis did not confirm the benefits of fish and fish oil in the secondary prevention of cardiac death and myocardial infarction. We performed a meta-analysis of randomized controlled trials that examined the effect of fish-oil supplementation on ventricular fibrillation and ventricular tachycardia to determine the overall effect and to assess whether heterogeneity exists between trials. METHODS: We searched electronic databases (MEDLINE, EMBASE, The Cochrane Central Register of Controlled Trials, CINAHL) from inception to May 2007. We included randomized controlled trials of fish-oil supplementation on ventricular fibrillation or ventricular tachycardia in patients with implantable cardioverter defibrillators. The primary outcome was implantable cardioverter defibrillator discharge. We calculated relative risk [RR] for outcomes at 1-year follow-up for each study. We used the DerSimonian and Laird random-effects methods when there was significant heterogeneity between trials and the Mantel-Hanzel fixed-effects method when heterogeneity was negligible. RESULTS: We identified 3 trials of 1-2 years' duration. These trials included a total of 573 patients who received fish oil and 575 patients who received a control. Meta-analysis of data collected at 1 year showed no overall effect of fish oil on the relative risk of implantable cardioverter defibrillator discharge. There was significant heterogeneity between trials. The second largest study showed a significant benefit of fish oil (relative risk [RR] 0.74, 95% confidence interval [CI] 0.56-0.98). The smallest showed an adverse tendency at 1 year (RR 1.23, 95% CI 0.92-1.65) and significantly worse outcome at 2 years among patients with ventricular tachycardia at study entry (log rank p = 0.007). CONCLUSION: These data indicate that there is heterogeneity in the response of patients to fish-oil supplementation. Caution should be used when prescribing fish-oil supplementation for patients with ventricular tachycardia.
Authors: M L Burr; A M Fehily; J F Gilbert; S Rogers; R M Holliday; P M Sweetnam; P C Elwood; N M Deadman Journal: Lancet Date: 1989-09-30 Impact factor: 79.321
Authors: Ram B Singh; Gal Dubnov; Mohammad A Niaz; Saraswati Ghosh; Reema Singh; Shanti S Rastogi; Orly Manor; Daniel Pella; Elliot M Berry Journal: Lancet Date: 2002-11-09 Impact factor: 79.321
Authors: Roberto Marchioli; Federica Barzi; Elena Bomba; Carmine Chieffo; Domenico Di Gregorio; Rocco Di Mascio; Maria Grazia Franzosi; Enrico Geraci; Giacomo Levantesi; Aldo Pietro Maggioni; Loredana Mantini; Rosa Maria Marfisi; G Mastrogiuseppe; Nicola Mininni; Gian Luigi Nicolosi; Massimo Santini; Carlo Schweiger; Luigi Tavazzi; Gianni Tognoni; Corrado Tucci; Franco Valagussa Journal: Circulation Date: 2002-04-23 Impact factor: 29.690
Authors: M L Burr; P A L Ashfield-Watt; F D J Dunstan; A M Fehily; P Breay; T Ashton; P C Zotos; N A A Haboubi; P C Elwood Journal: Eur J Clin Nutr Date: 2003-02 Impact factor: 4.016
Authors: I A Brouwer; P L Zock; E F D Wever; R N W Hauer; A J Camm; D Böcker; P Otto-Terlouw; M B Katan; E G Schouten Journal: Eur J Clin Nutr Date: 2003-10 Impact factor: 4.016
Authors: Gabriel Laurent; Gordon Moe; Xudong Hu; Bruce Holub; Howard Leong-Poi; Judy Trogadis; Kim Connelly; David Courtman; Bradley H Strauss; Paul Dorian Journal: Cardiovasc Res Date: 2007-09-20 Impact factor: 10.787
Authors: David J A Jenkins; John L Sievenpiper; Daniel Pauly; Ussif Rashid Sumaila; Cyril W C Kendall; Farley M Mowat Journal: CMAJ Date: 2009-03-17 Impact factor: 8.262
Authors: Hassan Fares; Carl J Lavie; James J DiNicolantonio; James H O'Keefe; Richard V Milani Journal: Curr Atheroscler Rep Date: 2014-02 Impact factor: 5.113
Authors: Thomas A Trikalinos; Denish Moorthy; Mei Chung; Winifred W Yu; Jounghee Lee; Alice H Lichtenstein; Joseph Lau Journal: J Clin Epidemiol Date: 2011-11-01 Impact factor: 6.437
Authors: Kristian B Filion; Fouad El Khoury; Michael Bielinski; Ian Schiller; Nandini Dendukuri; James M Brophy Journal: BMC Cardiovasc Disord Date: 2010-06-03 Impact factor: 2.298
Authors: Patrick J Smith; James A Blumenthal; Michael A Babyak; Anastasia Georgiades; Andrew Sherwood; Michael H Sketch; Lana L Watkins Journal: Am J Clin Nutr Date: 2009-03-25 Impact factor: 7.045
Authors: Ingeborg A Brouwer; Merritt H Raitt; Carla Dullemeijer; Dale F Kraemer; Peter L Zock; Cynthia Morris; Martijn B Katan; William E Connor; John A Camm; Evert G Schouten; John McAnulty Journal: Eur Heart J Date: 2009-02-04 Impact factor: 29.983